Cardiovascular Abnormalities in Children With Attention-deficit/Hyperactivity Disorder
1 other identifier
observational
100
0 countries
N/A
Brief Summary
To identify the prevalence and types of cardiovascular abnormalities in children diagnosed with ADHD
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2026
CompletedStudy Start
First participant enrolled
June 15, 2026
CompletedFirst Posted
Study publicly available on registry
June 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 15, 2028
June 18, 2026
June 1, 2026
1.3 years
June 4, 2026
June 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
prevalence of ECG and echocardiographic abnormalities in children with ADHD.
The percentage of children diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) who exhibit one or more predefined structural or functional cardiac abnormalities on electrocardiogram (ECG) or transthoracic echocardiography (Echo). Abnormalities will be defined as: ECG Abnormalities: Prolonged corrected QT interval (QTc \> 450\\text{ ms} for males, \> 460\\text{ ms} for females using Bazett's formula), pathologic T-wave inversions, conduction blocks (e.g., right bundle branch block), or arrhythmias (e.g., ventricular premature beats). Echocardiographic Abnormalities: Left ventricular hypertrophy, structural congenital heart defects, valvular regurgitation (mitral/tricuspid) graded as moderate or severe, or reduced systolic function (Left Ventricular Ejection Fraction \< 55\\%). All assessments will be performed by a single blinded investigator using standard pediatric clinical guidelines to ensure consistency
within one week of emrollment
systolic blood pressure
Comparison of systolic blood pressure (measured via a standard automated pediatric sphygmomanometer) across the study groups. Unit of Measure: Millimeters of mercury (mmHg)
within one week of enrollment
diastolic blood pressure
Comparison of systolic blood pressure (measured via a standard automated pediatric sphygmomanometer) across the study groups. Unit of Measure: Millimeters of mercury (mmHg)
within one week of enrollment
Secondary Outcomes (1)
body mass index
within one week of enrollment
Study Arms (2)
case group
: consisting of pediatric patients previously diagnosed with ADHD according to DSM/5 criteria currently receiving pharmacological treatment.
control group
composed of age and sex matched neurotypical children
Interventions
* Electrocardiography (ECG): Twelve-lead ECG will be taken using 12A ECG device . * Echocardiographic Measurements M-Mode echocardiographic measurements clinical history and examination
Eligibility Criteria
Participants will be divided into: * A case group: consisting of pediatric patients previously diagnosed with ADHD according to DSM/5 criteria currently receiving pharmacological treatment. * A control group: composed of age and sex matched neurotypical children.
You may qualify if:
- Case group :
- Age is \> 6 years and \<18 years old
- Both sex
- Patients diagnosed as having ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
- Currently receiving pharmacological treatment for at least six months
- Control group:
- Healthy, typically developing children , matched by age and sex to the case group
You may not qualify if:
- Age \> 18 years
- Patients who have a history of chronic diseases.
- Patients with established hereditary syndromes or chromosomal abnormalities as Down syndrome.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident
Study Record Dates
First Submitted
June 4, 2026
First Posted
June 18, 2026
Study Start
June 15, 2026
Primary Completion (Estimated)
October 15, 2027
Study Completion (Estimated)
April 15, 2028
Last Updated
June 18, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share